From the operative position of an industry regulated under the Food and Drugs Act and that is intended to be exempt from this bill, allow me to just provide an example from our world.
Under the Food and Drugs Act, all products are assumed to have risks attached to them. If there is any therapeutic benefit, there is a risk attached. The math really comes down to managing and ensuring that the benefits outweigh the risks, and that the products are used and labeled and regulated in such a way that the risks are minimized and the benefits are maximized. How that applies to non-health products in the consumer product domain is obviously a trickier matter. That's because under the Food and Drugs Act, we are not just regulating the safety of the product; we're also regulating the efficacy, what they offer, what benefit they give.
I don't know how that fits under the Canada Consumer Product Safety Act, which doesn't evaluate efficacy. It's a difficult question for us to answer.